Literature DB >> 27040952

Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.

David Stíbal1, Bruno Therrien2, Georg Süss-Fink1, Patrycja Nowak-Sliwinska3, Paul J Dyson3, Eva Čermáková4, Martina Řezáčová5, Pavel Tomšík6.   

Abstract

Four diruthenium trithiolato chlorambucil conjugates have been prepared via Steglich esterification from chlorambucil and the corresponding trithiolato precursors. All conjugates are highly cytotoxic towards human ovarian A2780 and A2780cisR cancer cell lines with IC50 values in the nanomolar range. The conjugates exhibit selectivity towards A2780 cells as compared to non-cancerous HEK293 cells, while being only slightly selective for RF24 and A2780cisR cells. In vivo, the conjugate [10]BF4 suppressed the growth of a solid Ehrlich tumor in immunocompetent NMRI mice but did not prolong their overall survival. The reactivity of the chlorambucil conjugates with glutathione, a potential target of the dinuclear ruthenium motive, and with the 2-deoxyguanosine 5'-monophosphate (dGMP-a model target of chlorambucil) was studied by mass spectrometry and NMR spectroscopy. The conjugates did not show catalytic activity for the oxidation of glutathione nor binding to nucleotides, indicating that glutathione oxidation and DNA alkylation are not key mechanisms of action. Four highly cytotoxic diruthenium trithiolato chlorambucil conjugates have been prepared. All conjugates exhibit selectivity towards A2780 cells as compared to HEK293 cells, while being only slightly active in RF24 and A2780cisR cells. In vivo, the best candidate suppressed the growth of a solid Ehrlich tumor in immunocompetent NMRI mice but did not prolong their overall survival.

Entities:  

Keywords:  Anticancer activity; Arene ruthenium; Chlorambucil; Dinuclear complexes; In vivo study

Mesh:

Substances:

Year:  2016        PMID: 27040952     DOI: 10.1007/s00775-016-1353-z

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  25 in total

1.  Rational design of an organometallic glutathione transferase inhibitor.

Authors:  Wee Han Ang; Lorien J Parker; Anastasia De Luca; Lucienne Juillerat-Jeanneret; Craig J Morton; Mario Lo Bello; Michael W Parker; Paul J Dyson
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

2.  Thermoresponsive chlorambucil derivatives for tumour targeting.

Authors:  Catherine M Clavel; Olivier Zava; Frédéric Schmitt; Blanka Halamoda Kenzaoui; Alexey A Nazarov; Lucienne Juillerat-Jeanneret; Paul J Dyson
Journal:  Angew Chem Int Ed Engl       Date:  2011-06-17       Impact factor: 15.336

3.  Efficient oxidation of cysteine and glutathione catalyzed by a dinuclear areneruthenium trithiolato anticancer complex.

Authors:  Federico Giannini; Georg Süss-Fink; Julien Furrer
Journal:  Inorg Chem       Date:  2011-10-07       Impact factor: 5.165

4.  Chlorambucil--still not bad: a reappraisal.

Authors:  Daniel Catovsky; Monica Else; Sue Richards
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-05-06

5.  Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential.

Authors:  Federico Giannini; Julien Furrer; Anne-Flore Ibao; Georg Süss-Fink; Bruno Therrien; Olivier Zava; Mathurin Baquie; Paul J Dyson; Petr Stěpnička
Journal:  J Biol Inorg Chem       Date:  2012-06-16       Impact factor: 3.358

6.  The alkylating properties of chlorambucil.

Authors:  G C Kundu; J R Schullek; I B Wilson
Journal:  Pharmacol Biochem Behav       Date:  1994-11       Impact factor: 3.533

Review 7.  Ruthenium complexes as anticancer agents.

Authors:  Irena Kostova
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 8.  Metal based drugs: from serendipity to design.

Authors:  Simon Paul Fricker
Journal:  Dalton Trans       Date:  2007-09-19       Impact factor: 4.390

Review 9.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

10.  Crystal structure of bis-[μ-(4-meth-oxy-phen-yl)methane-thiol-ato-κ(2) S:S]bis-[chlorido-(η(6)-1-isopropyl-4-methyl-benzene)-ruthenium(II)] chloro-form disolvate.

Authors:  David Stíbal; Georg Süss-Fink; Bruno Therrien
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-09-26
View more
  4 in total

Review 1.  Consensus guidelines for the use and interpretation of angiogenesis assays.

Authors:  Patrycja Nowak-Sliwinska; Kari Alitalo; Elizabeth Allen; Andrey Anisimov; Alfred C Aplin; Robert Auerbach; Hellmut G Augustin; David O Bates; Judy R van Beijnum; R Hugh F Bender; Gabriele Bergers; Andreas Bikfalvi; Joyce Bischoff; Barbara C Böck; Peter C Brooks; Federico Bussolino; Bertan Cakir; Peter Carmeliet; Daniel Castranova; Anca M Cimpean; Ondine Cleaver; George Coukos; George E Davis; Michele De Palma; Anna Dimberg; Ruud P M Dings; Valentin Djonov; Andrew C Dudley; Neil P Dufton; Sarah-Maria Fendt; Napoleone Ferrara; Marcus Fruttiger; Dai Fukumura; Bart Ghesquière; Yan Gong; Robert J Griffin; Adrian L Harris; Christopher C W Hughes; Nan W Hultgren; M Luisa Iruela-Arispe; Melita Irving; Rakesh K Jain; Raghu Kalluri; Joanna Kalucka; Robert S Kerbel; Jan Kitajewski; Ingeborg Klaassen; Hynda K Kleinmann; Pieter Koolwijk; Elisabeth Kuczynski; Brenda R Kwak; Koen Marien; Juan M Melero-Martin; Lance L Munn; Roberto F Nicosia; Agnes Noel; Jussi Nurro; Anna-Karin Olsson; Tatiana V Petrova; Kristian Pietras; Roberto Pili; Jeffrey W Pollard; Mark J Post; Paul H A Quax; Gabriel A Rabinovich; Marius Raica; Anna M Randi; Domenico Ribatti; Curzio Ruegg; Reinier O Schlingemann; Stefan Schulte-Merker; Lois E H Smith; Jonathan W Song; Steven A Stacker; Jimmy Stalin; Amber N Stratman; Maureen Van de Velde; Victor W M van Hinsbergh; Peter B Vermeulen; Johannes Waltenberger; Brant M Weinstein; Hong Xin; Bahar Yetkin-Arik; Seppo Yla-Herttuala; Mervin C Yoder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2018-08       Impact factor: 9.596

2.  Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii.

Authors:  Afonso P Basto; Joachim Müller; Riccardo Rubbiani; David Stibal; Federico Giannini; Georg Süss-Fink; Vreni Balmer; Andrew Hemphill; Gilles Gasser; Julien Furrer
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Dinuclear thiolato-bridged arene ruthenium complexes: from reaction conditions and mechanism to synthesis of new complexes.

Authors:  Hedvika Primasová; Silviya Ninova; Mario de Capitani; Jana Daepp; Ulrich Aschauer; Julien Furrer
Journal:  RSC Adv       Date:  2020-11-04       Impact factor: 4.036

4.  Coumarin-Tagged Dinuclear Trithiolato-Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity.

Authors:  Oksana Desiatkina; Emilia Păunescu; Martin Mösching; Nicoleta Anghel; Ghalia Boubaker; Yosra Amdouni; Andrew Hemphill; Julien Furrer
Journal:  Chembiochem       Date:  2020-06-16       Impact factor: 3.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.